Defective fibrinolysis is a factor in a variety of vascular diseases both arterial and venous. Therapeutic correction of the defect has been shown to be successful in recurrent venous thrombosis, cutaneous vasculitis and liposclerosis. Therapeutic correction in arterial diseases has yet to be fully evaluated.
AstrupT. Fibrinolysis: an overview. In DavidsonJFRowanRMSamamaMMDesnoyersPC. Eds. Progress in Chemical Fibrinolysis and Thrombolysis. Vol. 3Raven Press, New York1978; 1–57.
2.
KadishJL. Fibrin and atherogenesis - a hypothesis. Atherosclerosis1979; 33: 409–413.
3.
NilssonIM. Phenformin and ethylestrenol in recurrent venous thrombosis. In DavidsonJFSamamaMMDesnoyersPC. Eds. Progress in Chemical Fibrinolysis and ThrombolysisVol. 1Raven Press, New York1975; 1–12.
4.
JarrettPEMMorlandMBrowseNL. Treatment of Raynaud's phenomenon by fibrinolytic enhancement. Brit Med J1978; ii: 523–525.
5.
KwaanHC. Physiologic and pharmacologic implications of fibrinolysis. Artery1979; 5: 285–290.
6.
LipinskaILipinskiBGurewichV. Lipoproteins: Fibrinolytic activity and fibrinogen in patients with occlusive vascular disease and in the healthy subjects with a family history of heart attacks. Artery1979; 6: 254–264.
7.
ChakrabartiRHockingEDFearnleyGRMannRDAttwellTNJacksonD. Fibrinolytic activity and coronary artery disease. Lancet1968; i: 987–990.
8.
DavidsonJFWalkerID. Synthetic fibrinolytic agents. Progress in Cardiovascular Disease1979; 21: 375–396.
9.
KluftC. Blood fibrinolysis - Proactivators and activators in human plasma. Thesis: Dutch Efficiency Bureau Pijnacker, 1978.
10.
DavidsonJFLochheadMMcDonaldGAMcNicolGP. Fibrinolytic enhancement by Stanozolol: a double blind trial. Britt J Haemat1972; 22: 543–559.
11.
RosingDRRedwoodDRBrakmanPAstrupTEpsteinSE. Impairment of the diurnal fibrinolytic response in man. Circulation Research1973; 32: 752–758.
12.
WalkerIDDavidsonJFHuttonILawrieTD. Disordered fibrinolytic response in coronary heart disease: a coronary angiographic study. Proceedings of the 7th European Cardiology Congress, Amsterdam 1976; p.342 (abstract).
13.
MeadeTWChakrabartiRNorthWRS. Associations between fibrinolytic activity and other variables in an industrial population. Adv Exp Med and Biol1977; 83: 219–221.
14.
WalkerIDDavidsonJFLorimerARHuttonI. Defective fibrinolysis and coronary heart disease. Scot Med J1978; 23: 197 (abstract).
